MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.
Powles, Thomas 1,*; Eder, Joseph Paul 2; Fine, Gregg D. 3; Braiteh, Fadi S. 4; Loriot, Yohann 5; Cruz, Cristina 6; Bellmunt, Joaquim 7; Burris, Howard A. 8; Petrylak, Daniel P. 2; Teng, Siew-leng 3; Shen, Xiaodong 3; Boyd, Zachary 3; Hegde, Priti S. 3; Chen, Daniel S. 3; Vogelzang, Nicholas J. 9
[Letter]
Nature.
515(7528):558-562, November 27, 2014.
(Format: HTML, PDF)